EE200200128A - The use of dextrasoxane, a product and a method for the manufacture of a medicament for the treatment of psoriasis - Google Patents

The use of dextrasoxane, a product and a method for the manufacture of a medicament for the treatment of psoriasis

Info

Publication number
EE200200128A
EE200200128A EEP200200128A EEP200200128A EE200200128A EE 200200128 A EE200200128 A EE 200200128A EE P200200128 A EEP200200128 A EE P200200128A EE P200200128 A EEP200200128 A EE P200200128A EE 200200128 A EE200200128 A EE 200200128A
Authority
EE
Estonia
Prior art keywords
dextrasoxane
psoriasis
medicament
manufacture
treatment
Prior art date
Application number
EEP200200128A
Other languages
Estonian (et)
Inventor
Zarmanian Iervant
Rogan-Grgas Jadranka
Original Assignee
Cyathus Exquirere Pharmaforschungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyathus Exquirere Pharmaforschungs Gmbh filed Critical Cyathus Exquirere Pharmaforschungs Gmbh
Publication of EE200200128A publication Critical patent/EE200200128A/en
Publication of EE04871B1 publication Critical patent/EE04871B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
EEP200200128A 1999-09-10 2000-09-08 The use of dextrasoxane, a product and a method for the manufacture of a medicament for the treatment of psoriasis EE04871B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT155899 1999-09-10
US18380600P 2000-02-22 2000-02-22
PCT/EP2000/008879 WO2001019358A2 (en) 1999-09-10 2000-09-08 Use dexrazoxane for treating psoriasis

Publications (2)

Publication Number Publication Date
EE200200128A true EE200200128A (en) 2003-04-15
EE04871B1 EE04871B1 (en) 2007-08-15

Family

ID=25596169

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200128A EE04871B1 (en) 1999-09-10 2000-09-08 The use of dextrasoxane, a product and a method for the manufacture of a medicament for the treatment of psoriasis

Country Status (16)

Country Link
EP (1) EP1214073A2 (en)
KR (1) KR20020035131A (en)
CN (1) CN1378451A (en)
AU (1) AU7286500A (en)
BG (1) BG106428A (en)
BR (1) BR0013921A (en)
CA (1) CA2384685A1 (en)
CZ (1) CZ2002729A3 (en)
EE (1) EE04871B1 (en)
HR (1) HRPK20020201B1 (en)
HU (1) HUP0202791A3 (en)
MX (1) MXPA02002486A (en)
PL (1) PL354980A1 (en)
RU (1) RU2002106874A (en)
SK (1) SK2802002A3 (en)
WO (1) WO2001019358A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021053523A1 (en) * 2019-09-18 2021-03-25 Tryp Therapeutics Compositions and methods to improve the therapeutic benefit of bis-dioxopiperazines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941790A (en) * 1967-07-03 1976-03-02 National Research Development Corporation Bis diketopiperazines
GB1234935A (en) * 1967-07-03 1971-06-09 Nat Res Dev Piperazine derivatives
US4963679A (en) * 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
JPH09503749A (en) * 1993-07-23 1997-04-15 エルエックスアール バイオテクノロジー インコーポレイテッド Methods of treating apoptosis and related conditions

Also Published As

Publication number Publication date
WO2001019358A3 (en) 2001-10-04
HUP0202791A2 (en) 2003-01-28
EE04871B1 (en) 2007-08-15
CZ2002729A3 (en) 2002-07-17
HRPK20020201B1 (en) 2004-08-31
CA2384685A1 (en) 2001-03-22
BR0013921A (en) 2002-05-14
RU2002106874A (en) 2003-11-20
HRP20020201A2 (en) 2003-06-30
PL354980A1 (en) 2004-03-22
CN1378451A (en) 2002-11-06
EP1214073A2 (en) 2002-06-19
MXPA02002486A (en) 2004-09-10
HUP0202791A3 (en) 2003-02-28
WO2001019358A2 (en) 2001-03-22
BG106428A (en) 2003-04-30
KR20020035131A (en) 2002-05-09
SK2802002A3 (en) 2003-02-04
AU7286500A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
EE200300212A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic diseases
ATE472325T1 (en) INTRACORPORAL MEDICATIONS FOR THE PHOTODYNAMIC TREATMENT OF DISEASES
NO20013560D0 (en) Polymorphs of telmisartan, methods of preparation thereof and use thereof for the manufacture of a drug
NO324227B1 (en) Cyclopropyl-fused pyrrolidine-based compounds, pharmaceutical compositions and combinations containing them as well as the use thereof for the manufacture of medicaments for the treatment of diseases
BR0008053B1 (en) process and apparatus for the manufacture of disposable absorbent articles.
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
NO20041277L (en) Pharmaceutical preparations for the treatment of asthma.
ATE447947T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULINRESIENCE
NO20003288D0 (en) Preparations for the treatment of respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
NO20043000L (en) A preparation for the treatment of neurocerebrovascular diseases
NO20022087L (en) Procedure for the treatment of diabetes
ID30116A (en) PIRIDOPIRANOAZEPIN DECREASES, THE PRODUCTION AND USE OF THERAPY
NO20013958L (en) Medication for the treatment of high blood pressure
NO994165D0 (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
ID26612A (en) SICLOBUTENA DECLARATIONS, THEIR PRODUCTION AND THE USE OF THERAPY
NO20014648D0 (en) Compounds and methods for the treatment of asthma, allergies and inflammatory diseases
NO20015772L (en) Compounds and methods for the treatment of post-traumatic stress syndrome
ID30562A (en) COMPOUNDS OF NEW RIBOSA AROMATIC COMPOUNDS, THE METHOD OF PRODUCTION AND USE AS MEDICINE
NO20012106D0 (en) Drug for the treatment of bone pathobolism
NO20020784D0 (en) Medication for the treatment of fractures
AU2001249262A1 (en) Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
NO20014812D0 (en) Method of Providing Cosmetic / Medical Therapy
IL162509A (en) Use of deoxypeganine for the production of a drug for treating clinical depression

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20070908